Start-Up Previews (6/03)
Executive Summary
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Personalized Medicine, features profiles of Aureon Biosciences Corp., Favrille Inc. and Xanthus Life Sciences Inc. Plus these Start-Ups across Health Care: Cameron Health Inc., Dynogen Pharmaceuticals Inc., Functional Genetics Inc. and Tensys Medical Inc.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.